Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

391
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
391
Introduction To Survival Analysis01:18

Introduction To Survival Analysis

738
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
738
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

548
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
548
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

556
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
556
Actuarial Approach01:20

Actuarial Approach

284
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
284
Parametric Survival Analysis: Weibull and Exponential Methods01:14

Parametric Survival Analysis: Weibull and Exponential Methods

1.0K
Parametric survival analysis models survival data by assuming a specific probability distribution for the time until an event occurs. The Weibull and exponential distributions are two of the most commonly used methods in this context, due to their versatility and relatively straightforward application.
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...
1.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

PRO-PLATINUM: A randomized, double-blind, placebo controlled study to investigate the efficacy of a probiotic intervention on the gut and vaginal microbiome of ovarian cancer patients undergoing treatment with platinum chemotherapy.

Gynecologic oncology·2026
Same author

Predicting immune-related thyroiditis using polygenic risk scores in patients with advanced melanoma.

Journal for immunotherapy of cancer·2026
Same author

Power and sample-size estimation in human microbiome research.

Med (New York, N.Y.)·2026
Same author

The Oncology Research Information Exchange Network (ORIEN) - Building a real-world collaborative, patient-driven infrastructure for discovery research and precision oncology.

Research square·2026
Same author

How the Ketogenic Diet Shapes the Microbiome to Influence Cancer Immunotherapy Outcomes: An Exploration of Clinical Trials and Their Results.

Nutrition and cancer·2026
Same author

Phase II trial of combination radiation, hormone, and immunotherapy in grade group 5 prostate cancer.

Journal for immunotherapy of cancer·2026
Same journal

Beyond EML4: efficacy of targeted therapy in lung cancer patients with rare ALK fusions - a real-world retrospective analysis.

NPJ precision oncology·2026
Same journal

GLP-1 receptor agonist targets an AMPKα1-HIF1α-PFKFB3 metabolic vulnerability and enhances Lenvatinib response in hepatocellular carcinoma.

NPJ precision oncology·2026
Same journal

Redefining therapeutic horizons in thymic epithelial tumors: precision, combinations, and emerging biology.

NPJ precision oncology·2026
Same journal

Cell-free DNA dynamics and progression-free survival in metastatic gastroesophageal adenocarcinoma: insights from the REGIRI-PRODIGE 58 ancillary study.

NPJ precision oncology·2026
Same journal

OncoGen.AI: an integrated platform for automated genomic analysis and reporting in precision oncology.

NPJ precision oncology·2026
Same journal

Deep learning-driven MRI radiomics reveals biological subtypes and predicts recurrence risk in rectal cancer.

NPJ precision oncology·2026
See all related articles

Related Experiment Video

Updated: Jan 14, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.7K

ShinyEvents: harmonizing longitudinal data for real-world survival estimation.

Alyssa Obermayer1,2, Joshua Davis3, Divya Priyanka Talada3

  • 1H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA. Alyssa.Obermayer@Moffitt.org.

NPJ Precision Oncology
|January 12, 2026
PubMed
Summary
This summary is machine-generated.

ShinyEvents is a new web tool that analyzes patient treatment data over time. It links treatment events to survival outcomes, aiding in clinical research and data analysis.

More Related Videos

Measurement of Survival Time in Brachionus Rotifers: Synchronization of Maternal Conditions
05:18

Measurement of Survival Time in Brachionus Rotifers: Synchronization of Maternal Conditions

Published on: July 22, 2016

8.9K
Monitoring Neuronal Survival via Longitudinal Fluorescence Microscopy
07:02

Monitoring Neuronal Survival via Longitudinal Fluorescence Microscopy

Published on: January 19, 2019

6.8K

Related Experiment Videos

Last Updated: Jan 14, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.7K
Measurement of Survival Time in Brachionus Rotifers: Synchronization of Maternal Conditions
05:18

Measurement of Survival Time in Brachionus Rotifers: Synchronization of Maternal Conditions

Published on: July 22, 2016

8.9K
Monitoring Neuronal Survival via Longitudinal Fluorescence Microscopy
07:02

Monitoring Neuronal Survival via Longitudinal Fluorescence Microscopy

Published on: January 19, 2019

6.8K

Area of Science:

  • Oncology
  • Bioinformatics
  • Data Science

Background:

  • Longitudinal data analysis is crucial for understanding treatment outcomes.
  • Existing tools struggle to integrate multilayered time-series data and link treatments to survival.
  • This gap hinders comprehensive analysis of patient treatment courses.

Purpose of the Study:

  • To develop ShinyEvents, a web-based framework for complex longitudinal data analysis.
  • To enable integration of multilayered time-series data with survival analytics.
  • To facilitate transparent and reproducible collaboration between clinicians and data scientists.

Main Methods:

  • Developed ShinyEvents, a web-based framework for longitudinal data analysis.
  • Implemented interactive timelines for clinical events and cohort visualizations (Sankey, Swimmer diagrams).
  • Enabled inference of real-world progression-free survival (rwPFS) and survival analyses (Kaplan-Meier, Cox regression).

Main Results:

  • ShinyEvents allows cohort-level analyses, including treatment clustering and endpoint assignment.
  • The tool visualizes patient journeys and treatment lines effectively.
  • Case study on muscle-invasive bladder cancer patients showed cisplatin and gemcitabine improved rwPFS and overall survival.

Conclusions:

  • ShinyEvents offers a unified framework for integrating longitudinal real-world data with survival analytics.
  • The tool supports association of treatment lines with clinical outcomes.
  • ShinyEvents enhances collaborative research in oncology and data science.